Angiodynamics (ANGO) Total Liabilities (2011 - 2026)

Angiodynamics has reported Total Liabilities for 16 years, with the latest figure at $87.3 million in Q1 2026.

• For the quarter ending Q1 2026, Total Liabilities fell 12.28% year-over-year to $87.3 million; the trailing twelve-month figure through Feb 2026 stood at $87.3 million (down 12.28% YoY), and the FY2025 full-year result was $97.2 million, down 13.3% from the prior year.
• Total Liabilities for Q1 2026 stood at $87.3 million, down from $93.3 million in the prior quarter.
• The five-year high for Total Liabilities was $154.3 million in Q2 2023, with the low at $66.1 million in Q3 2023.
• Historically, Total Liabilities has averaged $110.8 million across 5 years, with a median of $104.8 million in 2024.
• Annual changes were most pronounced in 2023 — Total Liabilities tumbled 53.94% — and 2024, when it surged 46.72%.
• Angiodynamics' Total Liabilities stood at $150.2 million in 2022, then plunged by 34.51% to $98.4 million in 2023, then climbed by 6.49% to $104.8 million in 2024, then retreated by 10.91% to $93.3 million in 2025, then slipped by 6.46% to $87.3 million in 2026.
• The last three Total Liabilities figures came in at $87.3 million (Q1 2026), $93.3 million (Q4 2025), and $86.8 million (Q3 2025), per Business Quant data.